Many patients with MSA experience depression, anxiety, panic attacks, and cognitive impairment over the course of their disease. Depression has been found in over half (60%) of MSA patients and anxiety has been found in over 75%. Both are more common in patients with MSA-P and are tied to lower quality of life. Cognitive impairment may also occur in up to 75% of patients.
1. Non-pharmacologic treatment of psychiatric issues include:
2. Medications used to help with psychiatric issues include:
Copyright 2022 | Defeat MSA Alliance – 501(c)(3)